Pharmaceuticals, Biotechnology and Life Sciences
ZYNTEGLO is the first gene therapy approved for transfusion-dependent β-thalassemia (TDT) European marketing authorization for ZYNTEGLO follows the fastest assessment…
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–#INDstatus—PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for…
– Phase 1/2 Data Being Presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting Demonstrated TAK-788 Extended…
Advocating on behalf of cancer survivors on June 4, 2019, National Cancer Survivors Day BERWYN, Pa.–(BUSINESS WIRE)–AscellaHealth a specialty-focused pharmaceutical…
SAN FRANCISCO–(BUSINESS WIRE)–Atomwise Inc. today announced a multi-year agreement with Eli Lilly and Company to apply Atomwise’s patented artificial intelligence…
PARIS–(BUSINESS WIRE)–Servier and Taiho Oncology, Inc. a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today presented LONSURF® (trifluridine/tipiracil, TAS-102) clinical…
Industry Veteran Brings Specialized Expertise in Medical Affairs, Medical Device and Real-World Evidence to Key Leadership Role in Fast-Growing Region…
VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE American: CVM), a Phase 3 cancer immunotherapy company, today announced that it will be presenting…
SEONGNAM-SI, South Korea–(BUSINESS WIRE)–Qurient Co. Ltd. today announced positive results from the Phase 2a EBA (early bactericidal activity) clinical trial…
SAN DIEGO–(BUSINESS WIRE)–Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and…